For more than 10 years, BSG has been the innovator in engineered beads with differential physicochemical properties for sub-proteome separations including for example, albumin and hemoglobin removal.
This case study highlights representative journal publications whereby one or more of the BSG advantages (consumable, enrichment/depletion, functional integrity, on-bead digest) uniquely supports the research study goal. These investigations cover a range of diseases, including cancer, neurodegenerative, Covid-19, malaria, and cardiovascular.
Offered Free by: Biotech Support Group LLC
See All Resources from: Biotech Support Group LLC